Cadila Company Profile
✉ Email this page to a colleague
What is the competitive landscape for CADILA, and what generic and branded alternatives to CADILA drugs are available?
CADILA has forty-one approved drugs.
Summary for Cadila
| US Patents: | 0 |
| Tradenames: | 35 |
| Ingredients: | 35 |
| NDAs: | 41 |
| Patent Litigation for Cadila: | See patent lawsuits for Cadila |
Drugs and US Patents for Cadila
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cadila | TIZANIDINE HYDROCHLORIDE | tizanidine hydrochloride | TABLET;ORAL | 208187-001 | Mar 9, 2018 | AB | RX | No | No | ⤷ Subscribe | ⤷ Subscribe | ||||
| Cadila Pharms Ltd | TELMISARTAN | telmisartan | TABLET;ORAL | 208605-002 | Jul 25, 2017 | AB | RX | No | No | ⤷ Subscribe | ⤷ Subscribe | ||||
| Cadila Pharms Ltd | OLANZAPINE | olanzapine | TABLET;ORAL | 210022-005 | Feb 24, 2023 | AB | RX | No | No | ⤷ Subscribe | ⤷ Subscribe | ||||
| Cadila Pharms Ltd | HYDRALAZINE HYDROCHLORIDE | hydralazine hydrochloride | TABLET;ORAL | 203845-002 | Sep 18, 2014 | AA | RX | No | No | ⤷ Subscribe | ⤷ Subscribe | ||||
| Cadila Pharms Ltd | FOLIC ACID | folic acid | TABLET;ORAL | 202437-001 | Jan 27, 2014 | AA | RX | No | No | ⤷ Subscribe | ⤷ Subscribe | ||||
| Cadila Pharms Ltd | SILDENAFIL CITRATE | sildenafil citrate | TABLET;ORAL | 218045-003 | Nov 28, 2023 | AB | RX | No | No | ⤷ Subscribe | ⤷ Subscribe | ||||
| Cadila Pharms Ltd | GLYBURIDE | glyburide | TABLET;ORAL | 203379-003 | Jan 4, 2019 | AB1 | RX | No | No | ⤷ Subscribe | ⤷ Subscribe | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
